# Phase3-E2 Verification — Clinical Validation Kit

- Date: 2026-09-18
- Branch: codex/phase3e-e2-clinical-validation-kit
- Worktree: D:\Projects\YunQi-phase3e-e2
- Base SHA: ee226ac34082bc18226d6038933c8928c43667fe
- Final SHA: recorded after the E2 documentation commit

## Delivered

Added the E2 design/plan records and the controlled
docs/clinical-validation/phase3-e package:

- protocol.md;
- reference-cases.template.csv;
- reference-case-selection-guide.md;
- demo-feedback.template.md;
- gate-matrix.template.md;
- empty sessions/ and references/ directories; and
- updated top-level clinical-validation README.

## Safety audit

- expected rule values: absent;
- system actual values copied into expected fields: no;
- reviewer names or signatures invented: no;
- CONFIRMED claims: none;
- patient names, record numbers, national identifiers, and clinical records:
  absent;
- diagnosis, treatment, prescription, medication, risk, recommendation, and AI
  conclusions: absent.

All G1–G6 entries begin as NOT_RUN. E3 and E4 remain blocked until the
specified external evidence exists.

## Required gates

~~~
pnpm install --frozen-lockfile: PASS
pnpm contracts:check: PASS
pnpm test:workbench-governance: PASS
pnpm test:time-governance: PASS
git diff --check: PASS
~~~

The E2 change is documentation-only. Workbench production source,
packages, OpenAPI, Contract freeze artifacts, package.json, and
pnpm-lock.yaml are zero diff relative to Base SHA.

## Stop status

~~~
expert reference set: NOT_PRESENT
clinical Demo session: NOT_PRESENT
E3: BLOCKED_BY_CLINICAL_INPUT
E4: BLOCKED_BY_CLINICAL_FEEDBACK
~~~

No E3 regression fixture and no E4 remediation was attempted.
